Key result
Low-voltage area-guided ablation cuts atrial arrhythmia recurrence ~23% in persistent AF.
Why the study?
Low-voltage areas may represent arrhythmogenic substrate in persistent AF, but the benefit of adjunctive LVA-guided ablation remained uncertain.
Does adjunctive low-voltage area-guided ablation added to pulmonary vein isolation reduce atrial arrhythmia recurrence compared with non-LVA-guided ablation strategies in patients with persistent or non-paroxysmal atrial fibrillation?
Meta-Analysis (n=1,656)
Yes
Does adjunctive low-voltage area-guided ablation added to pulmonary vein isolation reduce atrial arrhythmia recurrence compared with non-LVA-guided ablation strategies in patients with persistent or non-paroxysmal atrial fibrillation?
In this meta-analysis of 8 RCTs (1,656 patients), adjunctive low-voltage area-guided ablation for persistent AF reduced atrial arrhythmia recurrence (RR 0.77) and repeat ablations (RR 0.69), though the benefit was heavily driven by a single trial (IDEAL-AF) and the 95% prediction interval crossed unity.
Answers are grounded in this paper and cite their sources.
Supports LVA-guided ablation to reduce recurrence and repeat procedures in persistent AF; extends IDEAL-AF but prediction interval crossing unity warrants confirmation.
Background Low‐voltage areas (LVAs) may represent arrhythmogenic substrate in persistent atrial fibrillation (AF), but the benefit of adjunctive LVA‐guided ablation remains uncertain. Methods We performed a PRISMA‐compliant systematic review and random‐effects meta‐analysis of randomized controlled trials comparing LVA‐guided ablation with non‐LVA‐guided strategies in persistent or non‐paroxysmal AF. Searches were updated through September 2, 2026. The primary outcome was atrial arrhythmia recurrence; time‐to‐event hazard ratios (HRs), repeat ablation, procedural outcomes, and safety were secondary outcomes. Results Eight randomized trials involving 1656 patients contributed to the primary analysis. LVA‐guided ablation reduced atrial arrhythmia recurrence (RR 0.77, 95% CI 0.65–0.91; p = 0.003; I 2 = 36.6%), although the 95% prediction interval included no benefit (0.51–1.17). The pooled HR was also favorable (HR 0.71, 95% CI 0.53–0.96; p = 0.026; I 2 = 67.2%). Omitting IDEAL‐AF attenuated both estimates and eliminated most heterogeneity. Mapping‐before‐randomization trials with documented LVAs did not differ from randomization‐before‐mapping trials (interaction p = 0.76). Repeat ablation was reduced (RR 0.69, 95% CI 0.49–0.97), while procedure time, fluoroscopy time, and major safety outcomes were not significantly different. Conclusions LVA‐guided ablation was associated with fewer atrial arrhythmia recurrences and repeat procedures, but the pooled effect was strongly influenced by IDEAL‐AF and remained heterogeneous across documented‐LVA trials. Standardized mapping and ablation protocols are needed before the magnitude of benefit can be considered established.
No takes yet. Share an insight, caveat, or question.
Kivan et al. (2026) conducted a meta-analysis in Persistent or non-paroxysmal atrial fibrillation (n=1,656). Low-voltage area (LVA)-guided ablation added to pulmonary vein isolation (PVI) vs. Non-LVA-guided control strategy (PVI alone or PVI combined with non-LVA-guided adjunctive lesions such as linear ablation, CFAE ablation, or non-PV triggers) was evaluated on Recurrence of atrial fibrillation or atrial tachyarrhythmia at each trial's fixed follow-up point (12-18 months) (RR 0.77, 95% CI 0.65-0.91, p=0.0025). Low-voltage area-guided ablation reduced atrial arrhythmia recurrence compared with non-LVA-guided ablation strategies in persistent AF.
Synapse has enriched 10 related papers. Consider them for comparative context: